MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2

M P Gillam1, D Nimbalkar1, L Sun1

  • 1Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Oncogene
|February 18, 2014
PubMed

Insights

Cyclin-dependent kinase 4 (CDK4) is essential for tumor development in the pituitary and pancreatic islet in mice with a disrupted Men1 gene. CDK4 acts as a critical downstream target for MEN1 tumor suppression, unlike CDK2.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Mammalian cell proliferation, including tumorigenic growth, is regulated by multiple cyclin-dependent kinases (CDKs) in a tissue-specific manner.
  • Mice lacking CDK4 (Cdk4(-/-)) exhibit hypoplasia in the pituitary and pancreatic islet, tissues targeted in Multiple Endocrine Neoplasia type 1 (MEN1).
  • Men1(+/-) mice, analogous to human MEN1 mutations, develop tumors in these neuroendocrine tissues.

Purpose of the Study:

  • To investigate the genetic interactions between Men1 loss and CDK activation in tumorigenesis.
  • To determine the specific roles of CDK4 and CDK2 in the development of pituitary and pancreatic islet tumors in Men1(+/-) mice.

Main Methods:

  • Examined the impact of Cdk4 or Cdk2 disruption on tumorigenesis in Men1(+/-) mice.
  • Analyzed tumor development, proliferation, and loss of heterozygosity (LOH) at the Men1 locus.
  • Utilized CDK4 and CDK2 knockdown in INS-1 insulinoma cells to assess effects on cell cycle progression and retinoblastoma protein (RB) phosphorylation.

Main Results:

  • Men1(+/-); Cdk4(-/-) mice showed no tumor development; pituitaries and islets remained hypoplastic with reduced proliferation.
  • Men1(+/-); Cdk2(-/-) mice exhibited tumorigenesis comparable to Men1(+/-) mice.
  • CDK4 knockdown significantly inhibited cell cycle progression and RB phosphorylation, while CDK2 knockdown had minimal effects.

Conclusions:

  • CDK4 is a critical downstream target of MEN1-dependent tumor suppression.
  • CDK4 is required for tumorigenic proliferation in the pituitary and pancreatic islet.
  • CDK2 is dispensable for tumorigenesis in these specific neuroendocrine cell types.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K